Q. I have stage 3 lung cancer, what are the chances of survival?
Doctor Answer is medically reviewed by SecondMedic medical review team.
The outlook for stage 3 lung cancer varies depending on factors such as the type of lung cancer, its location in the lungs, and how far it has spread. Generally speaking, patients with stage 3 non-small cell lung cancer (NSCLC) have a 5-year survival rate between 20-30%. This means that 20 to 30 out of 100 people who are diagnosed with NSCLC at this stage survive for at least 5 years after their diagnosis.
When it comes to treatment options, surgery is often recommended as the primary course of action. Radiation therapy may be necessary following surgery or in some cases used as a standalone treatment option if surgery isn't possible. Chemotherapy is generally included alongside either radiation or surgery and is used to help slow down and stop the growth of tumors. Additionally, certain targeted treatments directed at specific genetic mutations associated with certain types of lung cancers can offer additional benefit when combined with traditional therapy modalities such as chemotherapy and radiotherapy.
Overall, prognosis depends largely on individual patient circumstances including tumor size/location, overall health condition etc., but with proper diagnosis and early intervention good results can be expected even in advanced stages like stage 3 lung cancer.
Related Posts
Aptamil Pepti Infant Formula 0 to 12 Months Tin 400gm
Brand: Nutricia International Private Limited
₹2000.00₹1960.00
View Details
Neocate LCP Infant Formula Powder 400GM
Brand: Nutricia International Private Limited
